Phathom Pharmaceuticals, Inc. — Form 8-K
Filed September 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Phathom Pharmaceuticals filed a Form 8-K on 2026-09-29 reporting under Item 8.01 (Other Events). The actual text of the event is not provided in the filing document list — only metadata, XBRL taxonomy extensions, and filing headers are visible. No counterparties, dollar amounts, share counts, or material business changes can be identified from the available information.
Why this rating
Item 8.01 is catch-all disclosure; substance unknown. Without event details, cannot assess materiality relative to $555.5M market cap.
Extracted items
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.